Press releases Image EN FR Corporate / 21.04.2023 IBA First Quarter 2023 Business Update – Date Change Read more IBA First Quarter 2023 Business Update – Date Change
Presentations Image EN Corporate / 23.03.2023 IBA Full Year 2022 Results Press Release Publication Date & Conference Call Details Read more IBA Full Year 2022 Results Press Release Publication Date & Conference Call Details
Press releases Image FR EN Corporate / 23.03.2023 IBA Reports Full Year 2022 Results Read more IBA Reports Full Year 2022 Results
Press releases Image EN FR Corporate / 14.03.2023 IBA is looking for 100 new collaborators in Belgium by June 2023 Read more IBA is looking for 100 new collaborators in Belgium by June 2023
Press releases Image EN FR Corporate / 20.02.2023 IBA Notice of Full Year 2022 Results and Conference Call Read more IBA Notice of Full Year 2022 Results and Conference Call
Press releases Image EN FR Proton Therapy / 10.01.2023 IBA announces contract with Moffitt Cancer Center for a Proteus®ONE proton therapy solution in Florida, US Read more IBA announces contract with Moffitt Cancer Center for a Proteus®ONE proton therapy solution in Florida, US
Press releases Image EN FR Proton Therapy / 08.12.2022 IBA Wins 10 Proton Therapy System Contract in Spain Read more IBA Wins 10 Proton Therapy System Contract in Spain
Press releases Image FR EN Corporate / 17.11.2022 IBA Business Update – Third Quarter 2022 Read more IBA Business Update – Third Quarter 2022
Press releases Image EN FR Corporate / 16.11.2022 IBA – TRANSPARENCY NOTIFICATION Read more IBA – TRANSPARENCY NOTIFICATION
Press releases Image EN FR Corporate / 12.10.2022 IBA celebrates 35th [+1] anniversary with Belgian entrepreneurs and key players to commit to creating a leading sustainable Walloon region Read more IBA celebrates 35th [+1] anniversary with Belgian entrepreneurs and key players to commit to creating a leading sustainable Walloon region
Reports Image EN FR Corporate / 01.09.2022 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2022 Read more UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2022
Press releases Image EN FR Proton Therapy / 01.09.2022 The PROTECT-trial consortium enrolls first patient into proton therapy study Read more The PROTECT-trial consortium enrolls first patient into proton therapy study
Presentations Image EN Corporate / 31.08.2022 IBA Half Year Results 2022 Press release and presentation Read more IBA Half Year Results 2022 Press release and presentation
Press releases Image EN FR Corporate / 31.08.2022 IBA Reports Half Year 2022 Results Read more IBA Reports Half Year 2022 Results
Press releases Image EN FR Proton Therapy / 26.08.2022 IBA qualifies as the only supplier for second round of tender to provide ten proton therapy units across Spain Read more IBA qualifies as the only supplier for second round of tender to provide ten proton therapy units across Spain
Press releases Image EN FR Proton Therapy / 18.08.2022 IBA and Apollo Proton Cancer Centre sign a collaboration agreement to provide proton therapy training and education programs in Asia Read more IBA and Apollo Proton Cancer Centre sign a collaboration agreement to provide proton therapy training and education programs in Asia
Press releases Image EN FR Proton Therapy / 02.08.2022 IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy Read more IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy
Press releases Image EN FR Corporate / 11.07.2022 IBA Notice of Half Year 2022 Results and Conference Call Read more IBA Notice of Half Year 2022 Results and Conference Call
Press releases Image FR EN Proton Therapy / 30.06.2022 IBA launches the ConformalFLASH® Alliance Read more IBA launches the ConformalFLASH® Alliance